Cingulate Inc. CINGW
Nov 3, 2026, 9:43 AM EST
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 23.64K
- EPS (ttm)
- -1.73
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 101
- Open
- 0.0035
- Previous close
- 0.0029
- Day's range
- 0.0035 – 0.0035
- 52-week range
- 0.0035 – 0.0035
2Y 0.0000 (0.00%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.01
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -10.79M
- Total cash
- 10.04M
- Total debt
- 234.17K
- Return on equity
- -273.82%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cingulate.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CINGW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Altium Capital Management, LP | 7.56% | 270,000 | 16.20K | Sep 29, 2024 |
| Hudson Bay Capital Management Lp | 5.90% | 210,798 | 12.65K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.55% | 19,479 | 1.17K | Sep 29, 2024 |
| UBS Group AG | 0.34% | 12,297 | 737 | Sep 29, 2024 |
| Virtu Financial LLC | 0.31% | 11,159 | 669 | Sep 29, 2024 |
| GoalVest Advisory, LLC | 0.08% | 3,000 | 179 | Sep 29, 2024 |